{"id":877797,"date":"2025-08-21T07:05:01","date_gmt":"2025-08-21T11:05:01","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/castle-biosciences-to-participate-in-upcoming-investor-conferences\/"},"modified":"2025-08-21T07:05:01","modified_gmt":"2025-08-21T11:05:01","slug":"castle-biosciences-to-participate-in-upcoming-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/castle-biosciences-to-participate-in-upcoming-investor-conferences\/","title":{"rendered":"Castle Biosciences to Participate in Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">FRIENDSWOOD, Texas, Aug.  21, 2025  (GLOBE NEWSWIRE) &#8212; Castle Biosciences, Inc.\u00a0(Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to present a company overview at Baird\u2019s 2025 Global Healthcare Conference on Wednesday, Sept. 10, 2025, at 10:15 a.m. Eastern time.<\/p>\n<p>A live audio webcast of the Company\u2019s presentation will be available by visiting Castle Biosciences\u2019 website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VCOoIil0Oe7fixH0OXtbVuQPt46HfhyVS-wUqKkkoqnFlZBT61BtYw5GYCOyw2wyXVMlIWZsrvQvsyXl3SPDw-rl0r-gt9DTBYy9RXx8-ZtbtfZ7ca_Qyi-tNBx35g1eBcyTq-BaspdOBGTr2F3NETRPlg9oGnOMoYyAdfQCuZWu-_RrU_WwLc_3S9-9kXWf\" rel=\"nofollow\" target=\"_blank\">ir.castlebiosciences.com\/events-presentations\/<\/a>. A replay of the webcast will be available following the conclusion of the live broadcast.<\/p>\n<p>Castle will also be available for one-on-one investor meetings during the Wells Fargo 20<sup>th<\/sup> Annual Healthcare Conference on Sept. 4, 2025, and the 9<sup>th<\/sup> Annual Lake Street Best Ideas Growth (BIG9) Conference on Sept. 11, 2025. Meetings may be requested exclusively through Wells Fargo and Lake Street Capital Markets.<\/p>\n<p>\n        <strong>About Castle Biosciences<\/strong><br \/>\n        <br \/>Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and investors.<\/p>\n<p>Castle\u2019s current portfolio consists of tests for skin cancers, Barrett\u2019s esophagus and uveal melanoma.\u00a0Additionally, the Company has active research and development programs for tests in these and other diseases with high clinical need, including its test in development to help guide systemic therapy selection for patients with moderate-to-severe atopic dermatitis seeking biologic treatment. To learn more, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=UF5o871_NmjpMLGpmGsqKxf-PjWOiaX2oIhcvi6DSbivLrNvvJ6fAOXZjb07_oYRVxGvQYkrE1LOs1bEiZ3ntNyn1mOUJrVr8t6Y3YCBPec1_f01gALfLB26rijci7Kn\" rel=\"nofollow\" target=\"_blank\">www.CastleBiosciences.com<\/a> and connect with us on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=BuAzVSbavfy7FUoM1bUBKgRCkVodowIv3tvSGzHIKbzsDnBiQMASMbBkMOJsjGLSuv5toKO3SWIDovBvyHDrRCF6UDmsmi-ItQLcsjPZd4nTmJL3uxHxAAnsxhg8QXhP\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FLV_zjrQbahbdp648e5ZUKnCgrl_0G8ubNQ8K1fZKQJDGbasIMKv0KrBTT5hon4WoiWSYD-6KIfVlUwvFD2tsGw0qcQe-9KBDO7GEmH_n1w=\" rel=\"nofollow\" target=\"_blank\">Facebook<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wncrtW7_EKNcttgcJUn02LPF-aa-W5S6T0eRBkirNZAeeLJXrYx3OOMrdYlS-5giwrIlt69z1DF3FpAwYjkFevF2HS5w92Fcv5Lvb3P5830=\" rel=\"nofollow\" target=\"_blank\">X<\/a> and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Yt9jsZuFajkzH8MxXl6A0-zau_bwtP7MiVRB7w3VEb0kEpcW0uZ789yebFxVYL_DZYNe4GypK3wl3-GHCOukc_FyXU6D9SsNrKgMnObQAqs=\" rel=\"nofollow\" target=\"_blank\">Instagram<\/a>.\u202f<\/p>\n<p>DecisionDx-Melanoma, DecisionDx-CM<em>Seq<\/em>, i31-SLNB, i31-ROR, DecisionDx-SCC, MyPath Melanoma, TissueCypher, DecisionDx-UM, DecisionDx-PRAME and DecisionDx-UM<em>Seq<\/em> are trademarks of Castle Biosciences, Inc.<\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Camilla Zuckero<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=t9nmgVcIOICWetFr7Zt1Nx2BAp6L2hqTW4F_YA-iEPXbQjao-MTke79A0ERXL8qK2gZIPyzbuBr8ZDhYNh8wQhsQ8UllWqY_Y3b0y30nTHXBPSAWfGJGtrNBlUKMCmJd\" rel=\"nofollow\" target=\"_blank\">czuckero@castlebiosciences.com<\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Allison Marshall<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=yC-MTCZKkTBJrr2Ma_Or2IsNeciv_GhzXiN4LJEY5pfN8D7wbrRCnY6bpyw9H4MpmAatiqivi-LxKghmca6FiicNUxqofP0o7jbFAbqjEViamHK_P2e7oWPDeBqTd_jZ\" rel=\"nofollow\" target=\"_blank\">amarshall@castlebiosciences.com<\/a><\/p>\n<p>\n        <strong>Source: <\/strong>Castle Biosciences Inc.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxNTQ3OSM3MTA4MDAyIzIwOTYwNzQ=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NGIxZWY0ZDAtZjA2ZS00MmMxLTkxNWItZTNkNGViMTZlYjMxLTExMDc2NDUtMjAyNS0wOC0yMS1lbg==\/tiny\/Castle-Biosciences-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>FRIENDSWOOD, Texas, Aug. 21, 2025 (GLOBE NEWSWIRE) &#8212; Castle Biosciences, Inc.\u00a0(Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to present a company overview at Baird\u2019s 2025 Global Healthcare Conference on Wednesday, Sept. 10, 2025, at 10:15 a.m. Eastern time. A live audio webcast of the Company\u2019s presentation will be available by visiting Castle Biosciences\u2019 website at ir.castlebiosciences.com\/events-presentations\/. A replay of the webcast will be available following the conclusion of the live broadcast. Castle will also be available for one-on-one investor meetings during the Wells Fargo 20th Annual Healthcare Conference on Sept. 4, 2025, and the 9th Annual Lake Street Best Ideas Growth (BIG9) Conference on Sept. 11, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/castle-biosciences-to-participate-in-upcoming-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Castle Biosciences to Participate in Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-877797","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Castle Biosciences to Participate in Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/castle-biosciences-to-participate-in-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Castle Biosciences to Participate in Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"FRIENDSWOOD, Texas, Aug. 21, 2025 (GLOBE NEWSWIRE) &#8212; Castle Biosciences, Inc.\u00a0(Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to present a company overview at Baird\u2019s 2025 Global Healthcare Conference on Wednesday, Sept. 10, 2025, at 10:15 a.m. Eastern time. A live audio webcast of the Company\u2019s presentation will be available by visiting Castle Biosciences\u2019 website at ir.castlebiosciences.com\/events-presentations\/. A replay of the webcast will be available following the conclusion of the live broadcast. Castle will also be available for one-on-one investor meetings during the Wells Fargo 20th Annual Healthcare Conference on Sept. 4, 2025, and the 9th Annual Lake Street Best Ideas Growth (BIG9) Conference on Sept. 11, &hellip; Continue reading &quot;Castle Biosciences to Participate in Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/castle-biosciences-to-participate-in-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-21T11:05:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxNTQ3OSM3MTA4MDAyIzIwOTYwNzQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/castle-biosciences-to-participate-in-upcoming-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/castle-biosciences-to-participate-in-upcoming-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Castle Biosciences to Participate in Upcoming Investor Conferences\",\"datePublished\":\"2025-08-21T11:05:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/castle-biosciences-to-participate-in-upcoming-investor-conferences\\\/\"},\"wordCount\":288,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/castle-biosciences-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUxNTQ3OSM3MTA4MDAyIzIwOTYwNzQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/castle-biosciences-to-participate-in-upcoming-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/castle-biosciences-to-participate-in-upcoming-investor-conferences\\\/\",\"name\":\"Castle Biosciences to Participate in Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/castle-biosciences-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/castle-biosciences-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUxNTQ3OSM3MTA4MDAyIzIwOTYwNzQ=\",\"datePublished\":\"2025-08-21T11:05:01+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/castle-biosciences-to-participate-in-upcoming-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/castle-biosciences-to-participate-in-upcoming-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/castle-biosciences-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUxNTQ3OSM3MTA4MDAyIzIwOTYwNzQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUxNTQ3OSM3MTA4MDAyIzIwOTYwNzQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/castle-biosciences-to-participate-in-upcoming-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Castle Biosciences to Participate in Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Castle Biosciences to Participate in Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/castle-biosciences-to-participate-in-upcoming-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Castle Biosciences to Participate in Upcoming Investor Conferences - Market Newsdesk","og_description":"FRIENDSWOOD, Texas, Aug. 21, 2025 (GLOBE NEWSWIRE) &#8212; Castle Biosciences, Inc.\u00a0(Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to present a company overview at Baird\u2019s 2025 Global Healthcare Conference on Wednesday, Sept. 10, 2025, at 10:15 a.m. Eastern time. A live audio webcast of the Company\u2019s presentation will be available by visiting Castle Biosciences\u2019 website at ir.castlebiosciences.com\/events-presentations\/. A replay of the webcast will be available following the conclusion of the live broadcast. Castle will also be available for one-on-one investor meetings during the Wells Fargo 20th Annual Healthcare Conference on Sept. 4, 2025, and the 9th Annual Lake Street Best Ideas Growth (BIG9) Conference on Sept. 11, &hellip; Continue reading \"Castle Biosciences to Participate in Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/castle-biosciences-to-participate-in-upcoming-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2025-08-21T11:05:01+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxNTQ3OSM3MTA4MDAyIzIwOTYwNzQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/castle-biosciences-to-participate-in-upcoming-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/castle-biosciences-to-participate-in-upcoming-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Castle Biosciences to Participate in Upcoming Investor Conferences","datePublished":"2025-08-21T11:05:01+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/castle-biosciences-to-participate-in-upcoming-investor-conferences\/"},"wordCount":288,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/castle-biosciences-to-participate-in-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxNTQ3OSM3MTA4MDAyIzIwOTYwNzQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/castle-biosciences-to-participate-in-upcoming-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/castle-biosciences-to-participate-in-upcoming-investor-conferences\/","name":"Castle Biosciences to Participate in Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/castle-biosciences-to-participate-in-upcoming-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/castle-biosciences-to-participate-in-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxNTQ3OSM3MTA4MDAyIzIwOTYwNzQ=","datePublished":"2025-08-21T11:05:01+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/castle-biosciences-to-participate-in-upcoming-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/castle-biosciences-to-participate-in-upcoming-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/castle-biosciences-to-participate-in-upcoming-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxNTQ3OSM3MTA4MDAyIzIwOTYwNzQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxNTQ3OSM3MTA4MDAyIzIwOTYwNzQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/castle-biosciences-to-participate-in-upcoming-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Castle Biosciences to Participate in Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/877797","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=877797"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/877797\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=877797"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=877797"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=877797"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}